Safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6 - Scientific guideline
Table of contents
This guideline clarifies the safety and residue data requirements for applications for non-immunological veterinary medicinal products intended for limited markets but not eligible for authorisation under Article 23 of Regulation (EU) 2019/6.
Keywords: Availability, limited market, Article 4, Article 8, Article 23, eligibility, Regulation (EU) 2019/6, safety data, residue data